Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy

Published:2017-12-15 Issue:2 Volume:12 Page:268-275
ISSN:1932-2259
Container-title:Journal of Cancer Survivorship
language:en
Short-container-title:J Cancer Surviv

Author:

Neuner Joan M.,Shi Yushu,Kong Amanda L.,Kamaraju Sailaja,Smith Elizabeth C.,Smallwood Alicia J.,Laud Purushottam W.,Charlson John A.

Funder

American Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Oncology (nursing),Oncology

Link

http://link.springer.com/article/10.1007/s11764-017-0666-4/fulltext.html

Reference31 articles.

1. Early Breast Cancer Trialists’ Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341–52.

2. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60–2. https://doi.org/10.1016/S0140-6736(04)17666-6 .

3. Becker T, Lipscombe L, Narod S, Simmons C, Anderson GM, Rochon PA. Systematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancer. J Am Geriatr Soc. 2012;60(9):1761–7. https://doi.org/10.1111/j.1532-5415.2012.04107.x .

4. Yen TWF, Czypinski LK, Sparapani RA, Guo C, Laud PW, Pezzin LE, et al. Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. Cancer. 2011;117(2):398–405. https://doi.org/10.1002/cncr.25412 .

5. Vaz-Luis I, Keating NL, Lin NU, Lii H, Winer EP, Freedman RA. Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study. J Clin Oncol. 2014;32(9):927–34. https://doi.org/10.1200/JCO.2013.51.1261 .

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fracture Risk Among Older Cancer Survivors Compared With Older Adults Without a History of Cancer;JAMA Oncology;2023-01-01

2. Fracture risk and assessment in adults with cancer;Osteoporosis International;2022-12-13

3. The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors;Osteoporosis International;2022-06-14

4. Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy Is Associated With Decreased Fractures in Women With Breast Cancer;Journal of Bone and Mineral Research;2021-02-16

5. A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting;Journal of Cancer Survivorship;2021-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3